Cormorant Asset Management, LP Ideaya Biosciences, Inc. Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $7.05 Million - $8.91 Million	-205,000 Reduced 45.56%	245,000 $8.6 Million
Q4 2023 Feb 14, 2024	SELL	$24.59 - $35.83 $3.69 Million - $5.37 Million	-150,000 Reduced 25.0%	450,000 $16 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $3.33 Million - $6.38 Million	250,000 Added 71.43%	600,000 $14.1 Million
Q4 2022 Feb 14, 2023	SELL	$14.47 - $18.17 $988,590 - $1.24 Million	-68,320 Reduced 16.33%	350,000 $6.36 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $3.87 Million - $6.61 Million	418,320 New	418,320 $6.24 Million

216

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.31B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.